Navigation Links
Big Arrow Group Expands Global Capabilities with Addition of Anne de Schweinitz
Date:2/12/2009

NEW YORK, Feb. 12 /PRNewswire/ -- Big Arrow Group, a New York-based full-service strategic consulting and communications firm, today announced that Anne de Schweinitz has joined the company.

As a member of Big Arrow's leadership team, Ms. de Schweinitz will be responsible for driving business growth by ensuring the success of current client programs and by expanding Big Arrow's offerings and expertise, especially in the area of global pharmaceutical and healthcare consulting.

Ms. de Schweinitz brings deep experience in healthcare marketing and communications to Big Arrow Group. She joins the firm following nearly 10 years at MS&L, a global communications agency within the Publicis Groupe of companies, where she served most recently as senior vice president and global account director for the agency's largest healthcare client, Eli Lilly and Company. In addition to overseeing teams in North American and Europe working in the areas of diabetes, cardiovascular disease, women's health and erectile dysfunction, Anne worked closely with Lilly's U.S. and global brand teams to help align and reposition the company's broad offering in diabetes.

"Success as a global account director for major companies and brands, especially in highly regulated industries, requires exceptional strategic insight and creative savvy. Anne has built an excellent reputation as a trusted advisor to her clients, helping them address their most critical business needs through highly differentiated and influential communications programs," said Mike Marino, president and founder of Big Arrow Group.

Prior to joining MS&L's New York office in 2006, Ms. de Schweinitz held positions in San Francisco and London, where she led the agency's global accounts for sanofi-aventis as well as programs on behalf of numerous pharmaceutical, biotech, medical device and healthcare delivery companies in a wide range of therapeutic areas.

Before joining MS&L, Ms. de Schweinitz work for the University of California, San Francisco, where she helped drive internal communications and supported public relations activities for corporate, clinical and research news. She is a Phi Beta Kappa graduate of Rutgers University and is active in a number of community and arts organizations in the New York area.

About Big Arrow Group

Big Arrow Group is a full-service strategic consulting and communications firm specializing in global brand development, marketing planning and integrated communications, new product development and market research. The firm has redefined communications deliverables through research and case-tested strategies to provide their clients with practical, easily activated strategies that build and accelerate brand momentum. Founded in 2004, Big Arrow Group is headquartered in New York City.

Big Arrow Group provides strategic planning and corporate brand development in technology, healthcare, pharmaceutical and business-to-business for a wide range of clients, including Biocodex, Genzyme Corporation, Northeast Utilities and Bayer Schering Pharma. To learn more about the Big Arrow Group, please visit http://www.bigarrowgroup.com.


'/>"/>
SOURCE Big Arrow Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
2. Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting
3. Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Directors
4. Proxy Governance Joins ISS, Glass Lewis and Egan Jones in Recommending Arrow International Shareholders Vote to Approve the $45.50 Per Share Merger With Teleflex
5. Arrow International, Inc. Invites You to Join Its 2007 Annual Meeting of Shareholders on the Web
6. Arrow International Announces Annual Meeting Voting Results
7. Shareholder Class Action Filed Against Aetna Inc. by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
8. StemCor Systems Receives FDA Clearance for Bone Marrow Harvesting System
9. Study on Plasma-Depleted Cord Blood Transplantation Receives Best Abstract Award From The National Marrow Donor Program
10. Beactica Announces Drug Discovery Collaboration With Arrow Therapeutics
11. Narrow band imaging colonoscopy identifies flat dysplastic lesions in ulcerative colitis patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... 23, 2017 , ... The Lymphoma Research Foundation (LRF) – ... serving the lymphoma community through a comprehensive series of education programs, outreach initiatives ... Miami Beach to host its Swirl: Miami Wine Tasting Event on March 28, ...
(Date:2/23/2017)... ... February 23, 2017 , ... Los Angeles-based weight loss surgeon Michael Feiz, M.D., ... From Not to Hot,” which will begin airing on February 24, 2017. The show ... from the 2012 reality television series, “Here Comes Honey Boo Boo.” The earlier series ...
(Date:2/23/2017)... Mass. (PRWEB) , ... February 23, 2017 , ... ... as an approved content provider for the National Institute for Health and ... and social care-related organizations in the National Health Service (NHS) to search, order ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... exciting, new, interactive publication where generations converge and explore the world from different ... worldview, Dialog Magazine enables readers to gain understanding, increase empathy, and find greater ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... and community for those in the fight against cancer, has produced a seminal ... success. HRA will release top-line findings in a webinar, Defining Compassionate Care ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Feb. 23, 2017  The particle counters market ... 2021 from USD 275.9 million in 2016, at ... full report: http://www.reportlinker.com/p04718602-summary/view-report.html The ... pharmaceutical R&D, and growth in manufacturing industries in ... growth for particle counters. On the other hand, ...
(Date:2/23/2017)... , Feb 23, 2017 Research and Markets ... Price Analysis and Strategies - 2016" report to their offering. ... The latest ... provides drug pricing data and benchmarks in the global Autism Spectrum ... What are the key drugs marketed for Autism ...
(Date:2/23/2017)... Nevro Corp. (NYSE: NVRO), a global medical device company that ... pain, today reported financial results for the three months and ... Accomplishment & Highlights: Achieved revenue of $228.5 ... as reported, over the prior year U.S. revenue ... the prior year International revenue of $55.2 ...
Breaking Medicine Technology: